{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:59:09Z","timestamp":1791655149713,"version":"4.3.4"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"japan agency for medical research and development","doi-asserted-by":"publisher","award":["DNW-20019"],"award-info":[{"award-number":["DNW-20019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dengue, a rapidly spreading mosquito-borne human viral disease caused by dengue virus (DENV), is a public health concern in tropical and subtropical areas due to its expanding geographical range. DENV can cause a wide spectrum of illnesses in humans, ranging from asymptomatic infection or mild dengue fever (DF) to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Dengue is caused by four DENV serotypes; however, dengue pathogenesis is complex and poorly understood. Establishing a useful animal model that can exhibit dengue-fever-like signs similar to those in humans is essential to improve our understanding of the host response and pathogenesis of DENV. Although several animal models, including mouse models, non-human primate models, and a recently reported tree shrew model, have been investigated for DENV infection, animal models with clinical signs that are similar to those of DF in humans have not yet been established. Although animal models are essential for understanding the pathogenesis of DENV infection and for drug and vaccine development, each animal model has its own strengths and limitations. Therefore, in this review, we provide a recent overview of animal models for DENV infection and pathogenesis, focusing on studies of the antibody-dependent enhancement (ADE) effect in animal models.<\/jats:p>","DOI":"10.1007\/s00705-021-05298-2","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T17:37:15Z","timestamp":1636565835000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mammalian animal models for dengue virus infection: a recent overview"],"prefix":"10.1007","volume":"167","author":[{"given":"Mohammad Enamul Hoque","family":"Kayesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4403-2018","authenticated-orcid":false,"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"5298_CR1","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1038\/s41598-019-45816-6","volume":"9","author":"R Aguas","year":"2019","unstructured":"Aguas R, Dorigatti I, Coudeville L, Luxemburger C, Ferguson NM (2019) Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam. Sci Rep 9:9395","journal-title":"Sci Rep"},{"key":"5298_CR2","doi-asserted-by":"publisher","first-page":"e1002934","DOI":"10.1371\/journal.ppat.1002934","volume":"8","author":"S Aguirre","year":"2012","unstructured":"Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A (2012) DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8:e1002934","journal-title":"PLoS Pathog"},{"key":"5298_CR3","doi-asserted-by":"publisher","first-page":"e20169","DOI":"10.1371\/journal.pone.0020169","volume":"6","author":"R Akkina","year":"2011","unstructured":"Akkina R, Berges BK, Palmer BE, Remling L, Neff CP, Kuruvilla J, Connick E, Folkvord J, Gagliardi K, Kassu A, Akkina SR (2011) Humanized Rag1\u2212\/\u2212 gammac\u2212\/\u2212 mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS ONE 6:e20169","journal-title":"PLoS ONE"},{"key":"5298_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.virol.2014.01.015","volume":"452\u2013453","author":"BM Althouse","year":"2014","unstructured":"Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA (2014) Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis. Virology 452\u2013453:237\u2013246","journal-title":"Virology"},{"key":"5298_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/0035-9203(88)90224-6","volume":"82","author":"S Angsubhakorn","year":"1988","unstructured":"Angsubhakorn S, Yoksan S, Bhamarapravati N, Moe JB, Marchette NJ, Pradermwong A, Sahaphong S (1988) Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys. Trans R Soc Trop Med Hyg 82:746\u2013749","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5298_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","volume":"584","author":"AM Arvin","year":"2020","unstructured":"Arvin AM, Fink K, Schmid MA, Cathcart A, Spreafico R, Havenar-Daughton C, Lanzavecchia A, Corti D, Virgin HW (2020) A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature 584:353\u2013363","journal-title":"Nature"},{"key":"5298_CR7","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","volume":"6","author":"SJ Balsitis","year":"2010","unstructured":"Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6:e1000790","journal-title":"PLoS Pathog"},{"key":"5298_CR8","doi-asserted-by":"publisher","first-page":"e00440-18","DOI":"10.1128\/JVI.00440-18","volume":"92","author":"V Barban","year":"2018","unstructured":"Barban V, Mantel N, De Montfort A, Pagnon A, Pradezynski F, Lang J, Boudet F (2018) Improvement of the dengue virus (DENV) nonhuman primate model via a reverse translational approach based on dengue vaccine clinical efficacy data against DENV-2 and -4. J Virol 92:e00440-18","journal-title":"J Virol"},{"key":"5298_CR9","doi-asserted-by":"publisher","first-page":"13797","DOI":"10.1128\/JVI.79.21.13797-13799.2005","volume":"79","author":"DA Bente","year":"2005","unstructured":"Bente DA, Melkus MW, Garcia JV, Rico-Hesse R (2005) Dengue fever in humanized NOD\/SCID mice. J Virol 79:13797\u201313799","journal-title":"J Virol"},{"key":"5298_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.antiviral.2008.06.005","volume":"80","author":"L Bernardo","year":"2008","unstructured":"Bernardo L, Izquierdo A, Alvarez M, Rosario D, Prado I, Lopez C, Martinez R, Castro J, Santana E, Hermida L, Guillen G, Guzman MG (2008) Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res 80:194\u2013199","journal-title":"Antiviral Res"},{"key":"5298_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504\u2013507","journal-title":"Nature"},{"key":"5298_CR12","doi-asserted-by":"publisher","first-page":"e1007721","DOI":"10.1371\/journal.ppat.1007721","volume":"15","author":"MB Borges","year":"2019","unstructured":"Borges MB, Marchevsky RS, Carvalho Pereira R, da Silva MY, Almeida Mendes LG, Diniz-Mendes L, Cruz MA, Tahmaoui O, Baudart S, Freire M, Homma A, Schneider-Ohrum K, Vaughn DW, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L (2019) Detection of post-vaccination enhanced dengue virus infection in macaques: an improved model for early assessment of dengue vaccines. PLoS Pathog 15:e1007721","journal-title":"PLoS Pathog"},{"key":"5298_CR13","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1128\/jvi.70.6.4162-4166.1996","volume":"70","author":"M Bray","year":"1996","unstructured":"Bray M, Men R, Lai CJ (1996) Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol 70:4162\u20134166","journal-title":"J Virol"},{"key":"5298_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2011.11.072","volume":"30","author":"JN Brewoo","year":"2012","unstructured":"Brewoo JN, Kinney RM, Powell TD, Arguello JJ, Silengo SJ, Partidos CD, Huang CY, Stinchcomb DT, Osorio JE (2012) Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice. Vaccine 30:1513\u20131520","journal-title":"Vaccine"},{"key":"5298_CR15","first-page":"589","volume":"33","author":"S Butrapet","year":"2002","unstructured":"Butrapet S, Rabablert J, Angsubhakorn S, Wiriyarat W, Huang C, Kinney R, Punyim S, Bhamarapravati N (2002) Chimeric dengue type 2\/type 1 viruses induce immune responses in cynomolgus monkeys. Southeast Asian J Trop Med Public Health 33:589\u2013599","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5298_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ame2.12145","volume":"4","author":"AB Byrne","year":"2021","unstructured":"Byrne AB, Garcia AG, Brahamian JM, Mauri A, Ferretti A, Polack FP, Talarico LB (2021) A murine model of dengue virus infection in suckling C57BL\/6 and BALB\/c mice. Anim Model Exp Med 4:16\u201326","journal-title":"Anim Model Exp Med"},{"key":"5298_CR17","doi-asserted-by":"publisher","first-page":"001547","DOI":"10.1099\/jgv.0.001547","volume":"102","author":"S Cabezas-Falcon","year":"2021","unstructured":"Cabezas-Falcon S, Norbury AJ, Hulme-Jones J, Klebe S, Adamson P, Rudd PA, Mahalingam S, Ong LC, Alonso S, Gordon DL, Carr JM (2021) Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse. J Gen Virol 102:001547","journal-title":"J Gen Virol"},{"key":"5298_CR18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.celrep.2017.10.054","volume":"21","author":"AF Carlin","year":"2017","unstructured":"Carlin AF, Plummer EM, Vizcarra EA, Sheets N, Joo Y, Tang W, Day J, Greenbaum J, Glass CK, Diamond MS, Shresta S (2017) An IRF-3-, IRF-5-, and IRF-7-independent pathway of dengue viral resistance utilizes IRF-1 to stimulate type I and II interferon responses. Cell Rep 21:1600\u20131612","journal-title":"Cell Rep"},{"key":"5298_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4269\/ajtmh.19-0633","volume":"103","author":"LB Carrington","year":"2020","unstructured":"Carrington LB, Ponlawat A, Nitatsukprasert C, Khongtak P, Sunyakumthorn P, Ege CA, Im-Erbsin R, Chumpolkulwong K, Thaisomboonsuk B, Klungthong C, Yoon IK, Ellison D, Macareo L, Simmons CP (2020) Virological and immunological outcomes in rhesus monkeys after exposure to dengue virus-infected Aedes aegypti mosquitoes. Am J Trop Med Hyg 103:112\u2013119","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.coviro.2012.02.007","volume":"2","author":"R Carrion Jr","year":"2012","unstructured":"Carrion R Jr, Patterson JL (2012) An animal model that reflects human disease: the common marmoset (Callithrix jacchus). Curr Opin Virol 2:357\u2013362","journal-title":"Curr Opin Virol"},{"key":"5298_CR21","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1016\/j.vaccine.2010.04.045","volume":"28","author":"MC Cassetti","year":"2010","unstructured":"Cassetti MC, Durbin A, Harris E, Rico-Hesse R, Roehrig J, Rothman A, Whitehead S, Natarajan R, Laughlin C (2010) Report of an NIAID workshop on dengue animal models. Vaccine 28:4229\u20134234","journal-title":"Vaccine"},{"key":"5298_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.antiviral.2015.08.013","volume":"123","author":"KW Chan","year":"2015","unstructured":"Chan KW, Watanabe S, Kavishna R, Alonso S, Vasudevan SG (2015) Animal models for studying dengue pathogenesis and therapy. Antiviral Res 123:5\u201314","journal-title":"Antiviral Res"},{"key":"5298_CR23","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1128\/JVI.02575-06","volume":"81","author":"HC Chen","year":"2007","unstructured":"Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA (2007) Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81:5518\u20135526","journal-title":"J Virol"},{"key":"5298_CR24","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1128\/JVI.00996-07","volume":"81","author":"L Chen","year":"2007","unstructured":"Chen L, Ewing D, Subramanian H, Block K, Rayner J, Alterson KD, Sedegah M, Hayes C, Porter K, Raviprakash K (2007) A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. J Virol 81:11634\u201311639","journal-title":"J Virol"},{"key":"5298_CR25","doi-asserted-by":"publisher","first-page":"708817","DOI":"10.3389\/fitd.2021.708817","volume":"2","author":"T-Y Chen","year":"2021","unstructured":"Chen T-Y, Lee Y, Wang X, Mathias D, Caragata EP, Smartt CT (2021) Profiling transcriptional response of dengue-2 virus infection in midgut tissue of Aedes aegypti. Front Trop Dis 2:708817","journal-title":"Front Trop Dis"},{"key":"5298_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/vaccines8010039","volume":"8","author":"C Coronel-Ruiz","year":"2020","unstructured":"Coronel-Ruiz C, Gutierrez-Barbosa H, Medina-Moreno S, Velandia-Romero ML, Chua JV, Castellanos JE, Zapata JC (2020) Humanized mice in dengue research: a comparison with other mouse models. Vaccines (Basel) 8:39","journal-title":"Vaccines (Basel)"},{"key":"5298_CR27","doi-asserted-by":"publisher","first-page":"e1663","DOI":"10.1371\/journal.pntd.0001663","volume":"6","author":"VV Costa","year":"2012","unstructured":"Costa VV, Fagundes CT, Valadao DF, Cisalpino D, Dias AC, Silveira KD, Kangussu LM, Avila TV, Bonfim MR, Bonaventura D, Silva TA, Sousa LP, Rachid MA, Vieira LQ, Menezes GB, de Paula AM, Atrasheuskaya A, Ignatyev G, Teixeira MM, Souza DG (2012) A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-gamma in host resistance to infection. PLoS Negl Trop Dis 6:e1663","journal-title":"PLoS Negl Trop Dis"},{"key":"5298_CR28","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1128\/JVI.00534-12","volume":"86","author":"J Cox","year":"2012","unstructured":"Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R (2012) Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol 86:7637\u20137649","journal-title":"J Virol"},{"key":"5298_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745\u2013748","journal-title":"Science"},{"key":"5298_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","volume":"65","author":"AP Durbin","year":"2001","unstructured":"Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR, Thumar B, Men R, Lai CJ, Elkins WR, Chanock RM, Murphy BR, Whitehead SS (2001) Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region. Am J Trop Med Hyg 65:405\u2013413","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3389\/fimmu.2019.01316","volume":"10","author":"A Elong Ngono","year":"2019","unstructured":"Elong Ngono A, Shresta S (2019) Cross-reactive T cell immunity to dengue and Zika viruses: new insights into vaccine development. Front Immunol 10:1316","journal-title":"Front Immunol"},{"key":"5298_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41577-018-0005-7","volume":"18","author":"JD Estes","year":"2018","unstructured":"Estes JD, Wong SW, Brenchley JM (2018) Nonhuman primate models of human viral infections. Nat Rev Immunol 18:390\u2013404","journal-title":"Nat Rev Immunol"},{"key":"5298_CR33","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ncomms2416","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan Y, Huang ZY, Cao CC, Chen CS, Chen YX, Fan DD, He J, Hou HL, Hu L, Hu XT, Jiang XT, Lai R, Lang YS, Liang B, Liao SG, Mu D, Ma YY, Niu YY, Sun XQ, Xia JQ, Xiao J, Xiong ZQ, Xu L, Yang L, Zhang Y, Zhao W, Zhao XD, Zheng YT, Zhou JM, Zhu YB, Zhang GJ, Wang J, Yao YG (2013) Genome of the Chinese tree shrew. Nat Commun 4:1426","journal-title":"Nat Commun"},{"key":"5298_CR34","doi-asserted-by":"publisher","first-page":"525947","DOI":"10.1100\/2012\/525947","volume":"2012","author":"D Goncalves","year":"2012","unstructured":"Goncalves D, de Queiroz Prado R, Almeida Xavier E, Cristina de Oliveira N, da Matta Guedes PM, da Silva JS, Moraes Figueiredo LT, Aquino VH (2012) Immunocompetent mice model for dengue virus infection [corrected]. Sci World J 2012:525947","journal-title":"Sci World J"},{"key":"5298_CR35","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1073\/pnas.0703498104","volume":"104","author":"AP Goncalvez","year":"2007","unstructured":"Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 104:9422\u20139427","journal-title":"Proc Natl Acad Sci USA"},{"key":"5298_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imm.12188","volume":"141","author":"R Guabiraba","year":"2014","unstructured":"Guabiraba R, Ryffel B (2014) Dengue virus infection: current concepts in immune mechanisms and lessons from murine models. Immunology 141:143\u2013156","journal-title":"Immunology"},{"key":"5298_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2149\/tmh.2011-S05","volume":"39","author":"DJ Gubler","year":"2011","unstructured":"Gubler DJ (2011) Dengue, urbanization and globalization: the unholy trinity of the 21(st) century. Trop Med Health 39:3\u201311","journal-title":"Trop Med Health"},{"key":"5298_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4269\/ajtmh.2003.69.129","volume":"69","author":"MG Guzman","year":"2003","unstructured":"Guzman MG, Rodriguez R, Rodriguez R, Hermida L, Alvarez M, Lazo L, Mune M, Rosario D, Valdes K, Vazquez S, Martinez R, Serrano T, Paez J, Espinosa R, Pumariega T, Guillen G (2003) Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. Am J Trop Med Hyg 69:129\u2013134","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR39","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"MG Guzman","year":"2010","unstructured":"Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8:S7-16","journal-title":"Nat Rev Microbiol"},{"key":"5298_CR40","doi-asserted-by":"publisher","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","volume":"2","author":"MG Guzman","year":"2016","unstructured":"Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB (2016) Dengue infection. Nat Rev Dis Primers 2:16055","journal-title":"Nat Rev Dis Primers"},{"key":"5298_CR41","doi-asserted-by":"publisher","first-page":"100216","DOI":"10.1016\/j.onehlt.2021.100216","volume":"12","author":"SXW Gwee","year":"2021","unstructured":"Gwee SXW, St John AL, Gray GC, Pang J (2021) Animals as potential reservoirs for dengue transmission: a systematic review. One Health 12:100216","journal-title":"One Health"},{"key":"5298_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4269\/ajtmh.1973.22.365","volume":"22","author":"SB Halstead","year":"1973","unstructured":"Halstead SB, Casals J, Shotwell H, Palumbo N (1973) Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg 22:365\u2013374","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","volume":"128","author":"SB Halstead","year":"1973","unstructured":"Halstead SB, Shotwell H, Casals J (1973) Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis 128:7\u201314","journal-title":"J Infect Dis"},{"key":"5298_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","volume":"128","author":"SB Halstead","year":"1973","unstructured":"Halstead SB, Shotwell H, Casals J (1973) Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 128:15\u201322","journal-title":"J Infect Dis"},{"key":"5298_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","volume":"140","author":"SB Halstead","year":"1979","unstructured":"Halstead SB (1979) In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140:527\u2013533","journal-title":"J Infect Dis"},{"key":"5298_CR46","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/s41467-021-22930-6","volume":"12","author":"JP Hanley","year":"2021","unstructured":"Hanley JP, Tu HA, Dragon JA, Dickson DM, Rio-Guerra RD, Tighe SW, Eckstrom KM, Selig N, Scarpino SV, Whitehead SS, Durbin AP, Pierce KK, Kirkpatrick BD, Rizzo DM, Frietze S, Diehl SA (2021) Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model. Nat Commun 12:3054","journal-title":"Nat Commun"},{"key":"5298_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2000.63.5","volume":"63","author":"E Harris","year":"2000","unstructured":"Harris E, Videa E, Perez L, Sandoval E, Tellez Y, Perez ML, Cuadra R, Rocha J, Idiaquez W, Alonso RE, Delgado MA, Campo LA, Acevedo F, Gonzalez A, Amador JJ, Balmaseda A (2000) Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 63:5\u201311","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1128\/iai.18.1.151-156.1977","volume":"18","author":"VR Harrison","year":"1977","unstructured":"Harrison VR, Eckels KH, Sagartz JW, Russell PK (1977) Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun 18:151\u2013156","journal-title":"Infect Immun"},{"key":"5298_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4269\/ajtmh.13-0145","volume":"89","author":"AC Hickey","year":"2013","unstructured":"Hickey AC, Koster JA, Thalmann CM, Hardcastle K, Tio PH, Cardosa MJ, Bossart KN (2013) Serotype-specific host responses in rhesus macaques after primary dengue challenge. Am J Trop Med Hyg 89:1043\u20131057","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4149\/av_2019_309","volume":"63","author":"FC Jacome","year":"2019","unstructured":"Jacome FC, Teixeira AL, Coutinho DD, Costa AD, Caldas GC, Nunes MA, Barth OM, Barreto-Vieira DF (2019) Secondary dengue infection in immunocompetent murine model leads to heart tissue damage. Acta Virol 63:292\u2013300","journal-title":"Acta Virol"},{"key":"5298_CR51","doi-asserted-by":"publisher","first-page":"e7251","DOI":"10.1371\/journal.pone.0007251","volume":"4","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A (2009) Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE 4:e7251","journal-title":"PLoS ONE"},{"key":"5298_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1535370214546273","volume":"240","author":"S Jaiswal","year":"2015","unstructured":"Jaiswal S, Smith K, Ramirez A, Woda M, Pazoles P, Shultz LD, Greiner DL, Brehm MA, Mathew A (2015) Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice. Exp Biol Med (Maywood) 240:67\u201378","journal-title":"Exp Biol Med (Maywood)"},{"key":"5298_CR53","doi-asserted-by":"publisher","first-page":"621164","DOI":"10.3389\/fimmu.2021.621164","volume":"12","author":"L Jiang","year":"2021","unstructured":"Jiang L, Lu C, Sun Q (2021) Tree shrew as a new animal model for the study of dengue virus. Front Immunol 12:621164","journal-title":"Front Immunol"},{"key":"5298_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","volume":"73","author":"AJ Johnson","year":"1999","unstructured":"Johnson AJ, Roehrig JT (1999) New mouse model for dengue virus vaccine testing. J Virol 73:783\u2013786","journal-title":"J Virol"},{"key":"5298_CR55","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1099\/vir.0.055343-0","volume":"94","author":"F Kato","year":"2013","unstructured":"Kato F, Ishida Y, Kawagishi T, Kobayashi T, Hishiki T, Miura T, Igarashi T (2013) Natural infection of cynomolgus monkeys with dengue virus occurs in epidemic cycles in the Philippines. J Gen Virol 94:2202\u20132207","journal-title":"J Gen Virol"},{"key":"5298_CR56","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1038\/s41598-018-21582-9","volume":"8","author":"F Kato","year":"2018","unstructured":"Kato F, Ishida Y, Kawakami A, Takasaki T, Saijo M, Miura T, Hishiki T (2018) Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection. Sci Rep 8:3421","journal-title":"Sci Rep"},{"key":"5298_CR57","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E (2017) Antibody-dependent enhancement of severe dengue disease in humans. Science 358:929\u2013932","journal-title":"Science"},{"key":"5298_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.meegid.2017.04.003","volume":"51","author":"MEH Kayesh","year":"2017","unstructured":"Kayesh MEH, Kitab B, Sanada T, Hayasaka D, Morita K, Kohara M, Tsukiyama-Kohara K (2017) Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection. Infect Genet Evol 51:203\u2013210","journal-title":"Infect Genet Evol"},{"key":"5298_CR59","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/microorganisms7120686","volume":"7","author":"MEH Kayesh","year":"2019","unstructured":"Kayesh MEH, Hashem MA, Kitab B, Tsukiyama-Kohara K (2019) Pathogenesis and immune response caused by vector-borne and other viral infections in a Tupaia model. Microorganisms 7:686","journal-title":"Microorganisms"},{"key":"5298_CR60","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/v13081641","volume":"13","author":"MEH Kayesh","year":"2021","unstructured":"Kayesh MEH, Sanada T, Kohara M, Tsukiyama-Kohara K (2021) Tree shrew as an emerging small animal model for human viral infection: a recent overview. Viruses 13:1641","journal-title":"Viruses"},{"key":"5298_CR61","first-page":"3141","volume":"10","author":"C Koh","year":"2018","unstructured":"Koh C, Allen SL, Herbert RI, McGraw EA, Chenoweth SF (2018) The transcriptional response of Aedes aegypti with variable extrinsic incubation periods for dengue virus. Genome Biol Evol 10:3141\u20133151","journal-title":"Genome Biol Evol"},{"key":"5298_CR62","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"RJ Kuhn","year":"2002","unstructured":"Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717\u2013725","journal-title":"Cell"},{"key":"5298_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.virol.2007.06.005","volume":"369","author":"JG Kuruvilla","year":"2007","unstructured":"Kuruvilla JG, Troyer RM, Devi S, Akkina R (2007) Dengue virus infection and immune response in humanized RAG2(\u2212\/\u2212)gamma(c)(\u2212\/\u2212) (RAG-hu) mice. Virology 369:143\u2013152","journal-title":"Virology"},{"key":"5298_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.chom.2014.06.001","volume":"16","author":"M Kwissa","year":"2014","unstructured":"Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, Yoksan S, Pattanapanyasat K, Chokephaibulkit K, Ahmed R, Pulendran B (2014) Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16:115\u2013127","journal-title":"Cell Host Microbe"},{"key":"5298_CR65","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1128\/JVI.01420-07","volume":"81","author":"CJ Lai","year":"2007","unstructured":"Lai CJ, Goncalvez AP, Men R, Wernly C, Donau O, Engle RE, Purcell RH (2007) Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. J Virol 81:12766\u201312774","journal-title":"J Virol"},{"key":"5298_CR66","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1371\/journal.pntd.0000646","volume":"4","author":"L Lambrechts","year":"2010","unstructured":"Lambrechts L, Scott TW, Gubler DJ (2010) Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 4:e646","journal-title":"PLoS Negl Trop Dis"},{"key":"5298_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/infdis\/15.2.341","volume":"15","author":"CH Lavinder","year":"1914","unstructured":"Lavinder CH, Francis E (1914) The etiology of dengue. an attempt to produce the disease in the rhesus monkey by the inoculation of defibrinated blood. J Infect Dis 15:341\u2013346","journal-title":"J Infect Dis"},{"key":"5298_CR68","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fcimb.2017.00449","volume":"7","author":"GH Li","year":"2017","unstructured":"Li GH, Ning ZJ, Liu YM, Li XH (2017) Neurological manifestations of dengue infection. Front Cell Infect Microbiol 7:449","journal-title":"Front Cell Infect Microbiol"},{"key":"5298_CR69","doi-asserted-by":"publisher","first-page":"e1007716","DOI":"10.1371\/journal.ppat.1007716","volume":"15","author":"L Li","year":"2019","unstructured":"Li L, Meng W, Horton M, DiStefano DR, Thoryk EA, Pfaff JM, Wang Q, Salazar GT, Barnes T, Doranz BJ, Bett AJ, Casimiro DR, Vora KA, An Z, Zhang N (2019) Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes. PLoS Pathog 15:e1007716","journal-title":"PLoS Pathog"},{"key":"5298_CR70","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1128\/JVI.72.12.9729-9737.1998","volume":"72","author":"YL Lin","year":"1998","unstructured":"Lin YL, Liao CL, Chen LK, Yeh CT, Liu CI, Ma SH, Huang YY, Huang YL, Kao CL, King CC (1998) Study of dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 72:9729\u20139737","journal-title":"J Virol"},{"key":"5298_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2471\/BLT.16.189688","volume":"95","author":"SW Lindsay","year":"2017","unstructured":"Lindsay SW, Wilson A, Golding N, Scott TW, Takken W (2017) Improving the built environment in urban areas to control Aedes aegypti-borne diseases. Bull World Health Organ 95:607\u2013608","journal-title":"Bull World Health Organ"},{"key":"5298_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/128.1.23","volume":"128","author":"NJ Marchette","year":"1973","unstructured":"Marchette NJ, Halstead SB, Falkler WA Jr, Stenhouse A, Nash D (1973) Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis 128:23\u201330","journal-title":"J Infect Dis"},{"key":"5298_CR73","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1128\/JVI.78.9.4665-4674.2004","volume":"78","author":"R Men","year":"2004","unstructured":"Men R, Yamashiro T, Goncalvez AP, Wernly C, Schofield DJ, Emerson SU, Purcell RH, Lai CJ (2004) Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus. J Virol 78:4665\u20134674","journal-title":"J Virol"},{"key":"5298_CR74","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1099\/jgv.0.000923","volume":"98","author":"GN Milligan","year":"2017","unstructured":"Milligan GN, Sarathy VV, White MM, Greenberg MB, Campbell GA, Pyles RB, Barrett ADT, Bourne N (2017) A lethal model of disseminated dengue virus type 1 infection in AG129 mice. J Gen Virol 98:2507\u20132519","journal-title":"J Gen Virol"},{"key":"5298_CR75","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/pathogens2020357","volume":"2","author":"ML Moi","year":"2013","unstructured":"Moi ML, Omatsu T, Hirayama T, Nakamura S, Katakai Y, Yoshida T, Saito A, Tajima S, Ito M, Takasaki T, Akari H, Kurane I (2013) Presence of viral genome in urine and development of hematuria and pathological changes in kidneys in common marmoset (Callithrix jacchus) after inoculation with dengue virus. Pathogens 2:357\u2013363","journal-title":"Pathogens"},{"key":"5298_CR76","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1099\/vir.0.060384-0","volume":"95","author":"ML Moi","year":"2014","unstructured":"Moi ML, Takasaki T, Omatsu T, Nakamura S, Katakai Y, Ami Y, Suzaki Y, Saijo M, Akari H, Kurane I (2014) Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans. J Gen Virol 95:591\u2013600","journal-title":"J Gen Virol"},{"key":"5298_CR77","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4269\/ajtmh.14-0455","volume":"92","author":"ML Moi","year":"2015","unstructured":"Moi ML, Ami Y, Shirai K, Lim CK, Suzaki Y, Saito Y, Kitaura K, Saijo M, Suzuki R, Kurane I, Takasaki T (2015) Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus. Am J Trop Med Hyg 92:370\u2013376","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR78","doi-asserted-by":"publisher","first-page":"e00617-17","DOI":"10.1128\/JVI.00617-17","volume":"91","author":"J Morrison","year":"2017","unstructured":"Morrison J, Rathore APS, Mantri CK, Aman SAB, Nishida A, St John AL (2017) Transcriptional profiling confirms the therapeutic effects of mast cell stabilization in a dengue disease model. J Virol 91:e00617-17","journal-title":"J Virol"},{"key":"5298_CR79","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1128\/JVI.00581-09","volume":"83","author":"J Mota","year":"2009","unstructured":"Mota J, Rico-Hesse R (2009) Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 83:8638\u20138645","journal-title":"J Virol"},{"key":"5298_CR80","doi-asserted-by":"publisher","first-page":"e20762","DOI":"10.1371\/journal.pone.0020762","volume":"6","author":"J Mota","year":"2011","unstructured":"Mota J, Rico-Hesse R (2011) Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS ONE 6:e20762","journal-title":"PLoS ONE"},{"key":"5298_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/pathogens9040247","volume":"9","author":"NA Muhammad Azami","year":"2020","unstructured":"Muhammad Azami NA, Takasaki T, Kurane I, Moi ML (2020) Non-human primate models of dengue virus infection: a comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys. Pathogens 9:247","journal-title":"Pathogens"},{"key":"5298_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","volume":"29","author":"BR Murphy","year":"2011","unstructured":"Murphy BR, Whitehead SS (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29:587\u2013619","journal-title":"Annu Rev Immunol"},{"key":"5298_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7774\/cevr.2017.6.2.104","volume":"6","author":"W Na","year":"2017","unstructured":"Na W, Yeom M, Choi IK, Yook H, Song D (2017) Animal models for dengue vaccine development and testing. Clin Exp Vaccine Res 6:104\u2013110","journal-title":"Clin Exp Vaccine Res"},{"key":"5298_CR84","doi-asserted-by":"publisher","first-page":"e1004031","DOI":"10.1371\/journal.ppat.1004031","volume":"10","author":"JK Ng","year":"2014","unstructured":"Ng JK, Zhang SL, Tan HC, Yan B, Martinez JM, Tan WY, Lam JH, Tan GK, Ooi EE, Alonso S (2014) First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PLoS Pathog 10:e1004031","journal-title":"PLoS Pathog"},{"key":"5298_CR85","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1099\/vir.0.031229-0","volume":"92","author":"T Omatsu","year":"2011","unstructured":"Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I (2011) Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 92:2272\u20132280","journal-title":"J Gen Virol"},{"key":"5298_CR86","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","volume":"115","author":"N Onlamoon","year":"2010","unstructured":"Onlamoon N, Noisakran S, Hsiao HM, Duncan A, Villinger F, Ansari AA, Perng GC (2010) Dengue virus-induced hemorrhage in a nonhuman primate model. Blood 115:1823\u20131834","journal-title":"Blood"},{"key":"5298_CR87","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.virol.2005.04.042","volume":"338","author":"MV Paes","year":"2005","unstructured":"Paes MV, Pinhao AT, Barreto DF, Costa SM, Oliveira MP, Nogueira AC, Takiya CM, Farias-Filho JC, Schatzmayr HG, Alves AM, Barth OM (2005) Liver injury and viremia in mice infected with dengue-2 virus. Virology 338:236\u2013246","journal-title":"Virology"},{"key":"5298_CR88","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1128\/JVI.00365-09","volume":"83","author":"ST Perry","year":"2009","unstructured":"Perry ST, Prestwood TR, Lada SM, Benedict CA, Shresta S (2009) Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol 83:8276\u20138281","journal-title":"J Virol"},{"key":"5298_CR89","doi-asserted-by":"publisher","first-page":"e1001297","DOI":"10.1371\/journal.ppat.1001297","volume":"7","author":"ST Perry","year":"2011","unstructured":"Perry ST, Buck MD, Lada SM, Schindler C, Shresta S (2011) STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog 7:e1001297","journal-title":"PLoS Pathog"},{"key":"5298_CR90","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson TC, Diamond MS (2020) The continued threat of emerging flaviviruses. Nat Microbiol 5:796\u2013812","journal-title":"Nat Microbiol"},{"key":"5298_CR91","doi-asserted-by":"publisher","first-page":"e01316-01315","DOI":"10.1128\/mBio.01316-15","volume":"6","author":"AK Pinto","year":"2015","unstructured":"Pinto AK, Brien JD, Lam CY, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS (2015) Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection. MBio 6:e01316-01315","journal-title":"MBio"},{"key":"5298_CR92","doi-asserted-by":"publisher","first-page":"e1966","DOI":"10.1371\/journal.pntd.0001966","volume":"6","author":"SJ Popper","year":"2012","unstructured":"Popper SJ, Gordon A, Liu M, Balmaseda A, Harris E, Relman DA (2012) Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children. PLoS Negl Trop Dis 6:e1966","journal-title":"PLoS Negl Trop Dis"},{"key":"5298_CR93","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3390\/ijms22062879","volume":"22","author":"I Puc","year":"2021","unstructured":"Puc I, Ho TC, Yen KL, Vats A, Tsai JJ, Chen PL, Chien YW, Lo YC, Perng GC (2021) Cytokine signature of dengue patients at different severity of the disease. Int J Mol Sci 22:2879","journal-title":"Int J Mol Sci"},{"key":"5298_CR94","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1073\/pnas.1812055115","volume":"116","author":"R Raut","year":"2019","unstructured":"Raut R, Corbett KS, Tennekoon RN, Premawansa S, Wijewickrama A, Premawansa G, Mieczkowski P, Ruckert C, Ebel GD, De Silva AD, de Silva AM (2019) Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. Proc Natl Acad Sci USA 116:227\u2013232","journal-title":"Proc Natl Acad Sci USA"},{"key":"5298_CR95","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virol.2006.05.005","volume":"353","author":"K Raviprakash","year":"2006","unstructured":"Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K (2006) A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. Virology 353:166\u2013173","journal-title":"Virology"},{"key":"5298_CR96","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1128\/JVI.02724-07","volume":"82","author":"K Raviprakash","year":"2008","unstructured":"Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K (2008) A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J Virol 82:6927\u20136934","journal-title":"J Virol"},{"key":"5298_CR97","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","volume":"23","author":"J Robert Putnak","year":"2005","unstructured":"Robert Putnak J, Coller BA, Voss G, Vaughn DW, Clements D, Peters I, Bignami G, Houng HS, Chen RC, Barvir DA, Seriwatana J, Cayphas S, Garcon N, Gheysen D, Kanesa-Thasan N, McDonell M, Humphreys T, Eckels KH, Prieels JP, Innis BL (2005) An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine 23:4442\u20134452","journal-title":"Vaccine"},{"key":"5298_CR98","doi-asserted-by":"publisher","DOI":"10.21236\/AD1014518","volume-title":"Yucatan miniature swine as an animal model for dengue-1 disease","author":"JS Robinson","year":"2005","unstructured":"Robinson JS (2005) Yucatan miniature swine as an animal model for dengue-1 disease. Uniformed Services University of The Health Sciences, Bethesda"},{"key":"5298_CR99","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.101.2634.640","volume":"101","author":"AB Sabin","year":"1945","unstructured":"Sabin AB, Schlesinger RW (1945) Production of immunity to dengue with virus modified by propagation in mice. Science 101:640\u2013642","journal-title":"Science"},{"key":"5298_CR100","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tice.2016.11.005","volume":"49","author":"S Sakinah","year":"2017","unstructured":"Sakinah S, Priya SP, Kumari S, Amira F, Poorani K, Alsaeedy H, Ling MP, Chee HY, Higuchi A, Alarfaj AA, Munusamy MA, Murugan K, Taib CN, Arulselvan P, Rajan M, Neela VK, Hamat RA, Benelli G, Kumar SS (2017) Impact of dengue virus (serotype DENV-2) infection on liver of BALB\/c mice: a histopathological analysis. Tissue Cell 49:86\u201394","journal-title":"Tissue Cell"},{"key":"5298_CR101","doi-asserted-by":"publisher","first-page":"12372","DOI":"10.1038\/s41598-019-48867-x","volume":"9","author":"T Sanada","year":"2019","unstructured":"Sanada T, Tsukiyama-Kohara K, Shin IT, Yamamoto N, Kayesh MEH, Yamane D, Takano JI, Shiogama Y, Yasutomi Y, Ikeo K, Gojobori T, Mizokami M, Kohara M (2019) Construction of complete Tupaia belangeri transcriptome database by whole-genome and comprehensive RNA sequencing. Sci Rep 9:12372","journal-title":"Sci Rep"},{"key":"5298_CR102","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1099\/jgv.0.000246","volume":"96","author":"VV Sarathy","year":"2015","unstructured":"Sarathy VV, Infante E, Li L, Campbell GA, Wang T, Paessler S, Robert Beatty P, Harris E, Milligan GN, Bourne N, Barrett ADT (2015) Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-alpha\/beta and IFN-gamma receptors (AG129) and comparison with the DENV-2 AG129 mouse model. J Gen Virol 96:3035\u20133048","journal-title":"J Gen Virol"},{"key":"5298_CR103","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1128\/JVI.01320-14","volume":"89","author":"VV Sarathy","year":"2015","unstructured":"Sarathy VV, White M, Li L, Gorder SR, Pyles RB, Campbell GA, Milligan GN, Bourne N, Barrett AD (2015) A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J Virol 89:1254\u20131266","journal-title":"J Virol"},{"key":"5298_CR104","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1038\/s41598-018-22618-w","volume":"8","author":"VV Sarathy","year":"2018","unstructured":"Sarathy VV, White M, Li L, Kaiser JA, Campbell GA, Milligan GN, Bourne N, Barrett ADT (2018) Characterization of a murine model of non-lethal, symptomatic dengue virus infection. Sci Rep 8:4900","journal-title":"Sci Rep"},{"key":"5298_CR105","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1128\/CVI.00052-07","volume":"14","author":"CA Sariol","year":"2007","unstructured":"Sariol CA, Munoz-Jordan JL, Abel K, Rosado LC, Pantoja P, Giavedoni L, Rodriguez IV, White LJ, Martinez M, Arana T, Kraiselburd EN (2007) Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol 14:756\u2013766","journal-title":"Clin Vaccine Immunol"},{"key":"5298_CR106","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4269\/ajtmh.1978.27.590","volume":"27","author":"WF Scherer","year":"1978","unstructured":"Scherer WF, Russell PK, Rosen L, Casals J, Dickerman RW (1978) Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg 27:590\u2013599","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR107","doi-asserted-by":"publisher","first-page":"e1005676","DOI":"10.1371\/journal.ppat.1005676","volume":"12","author":"MA Schmid","year":"2016","unstructured":"Schmid MA, Glasner DR, Shah S, Michlmayr D, Kramer LD, Harris E (2016) Mosquito saliva increases endothelial permeability in the skin, immune cell migration, and dengue pathogenesis during antibody-dependent enhancement. PLoS Pathog 12:e1005676","journal-title":"PLoS Pathog"},{"key":"5298_CR108","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.4049\/jimmunol.175.6.3946","volume":"175","author":"S Shresta","year":"2005","unstructured":"Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E (2005) Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 175:3946\u20133954","journal-title":"J Immunol"},{"key":"5298_CR109","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1128\/JVI.00062-06","volume":"80","author":"S Shresta","year":"2006","unstructured":"Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E (2006) Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 80:10208\u201310217","journal-title":"J Virol"},{"key":"5298_CR110","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"CP Simmons","year":"2012","unstructured":"Simmons CP, Farrar JJ, Nguyen VV, Wills B (2012) Dengue. N Engl J Med 366:1423\u20131432","journal-title":"N Engl J Med"},{"key":"5298_CR111","doi-asserted-by":"crossref","unstructured":"Simon-Loriere E, Duong V, Tawfik A, Ung S, Ly S, Casademont I, Prot M, Courtejoie N, Bleakley K, Buchy P, Tarantola A, Dussart P, Cantaert T, Sakuntabhai A (2017) Increased adaptive immune responses and proper feedback regulation protect against clinical dengue. Sci Transl Med 9:eaal5088","DOI":"10.1126\/scitranslmed.aal5088"},{"key":"5298_CR112","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascarenas C, Frago C, Cortes M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng SP, Gilbert PB, Gurunathan S, DiazGranados CA (2018) Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 379:327\u2013340","journal-title":"N Engl J Med"},{"key":"5298_CR113","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1160\/TH09-03-0208","volume":"102","author":"A Srikiatkhachorn","year":"2009","unstructured":"Srikiatkhachorn A (2009) Plasma leakage in dengue haemorrhagic fever. Thromb Haemost 102:1042\u20131049","journal-title":"Thromb Haemost"},{"key":"5298_CR114","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","volume":"19","author":"AL St John","year":"2019","unstructured":"St John AL, Rathore APS (2019) Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol 19:218\u2013230","journal-title":"Nat Rev Immunol"},{"key":"5298_CR115","doi-asserted-by":"publisher","first-page":"e31919","DOI":"10.7554\/eLife.31919","volume":"7","author":"AC Stabell","year":"2018","unstructured":"Stabell AC, Meyerson NR, Gullberg RC, Gilchrist AR, Webb KJ, Old WM, Perera R, Sawyer SL (2018) Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir. Elife 7:e31919","journal-title":"Elife"},{"key":"5298_CR116","doi-asserted-by":"publisher","first-page":"e0004731","DOI":"10.1371\/journal.pntd.0004731","volume":"10","author":"FR Strouts","year":"2016","unstructured":"Strouts FR, Popper SJ, Partidos CD, Stinchcomb DT, Osorio JE, Relman DA (2016) Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates. PLoS Negl Trop Dis 10:e0004731","journal-title":"PLoS Negl Trop Dis"},{"key":"5298_CR117","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1371\/journal.ppat.0030132","volume":"3","author":"LM Styer","year":"2007","unstructured":"Styer LM, Kent KA, Albright RG, Bennett CJ, Kramer LD, Bernard KA (2007) Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog 3:1262\u20131270","journal-title":"PLoS Pathog"},{"key":"5298_CR118","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1086\/503372","volume":"193","author":"W Sun","year":"2006","unstructured":"Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, Vaughn DW, Innis BL, Thomas SJ, Endy TP (2006) Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 193:1658\u20131665","journal-title":"J Infect Dis"},{"key":"5298_CR119","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ebiom.2017.04.033","volume":"20","author":"LB Talarico","year":"2017","unstructured":"Talarico LB, Batalle JP, Byrne AB, Brahamian JM, Ferretti A, Garcia AG, Mauri A, Simonetto C, Hijano DR, Lawrence A, Acosta PL, Caballero MT, Paredes Rojas Y, Ibanez LI, Melendi GA, Rey FA, Damonte EB, Harris E, Polack FP (2017) The role of heterotypic DENV-specific CD8(+)T lymphocytes in an immunocompetent mouse model of secondary dengue virus infection. EBioMedicine 20:202\u2013216","journal-title":"EBioMedicine"},{"key":"5298_CR120","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/vaccines7040145","volume":"7","author":"N Tremblay","year":"2019","unstructured":"Tremblay N, Freppel W, Sow AA, Chatel-Chaix L (2019) The interplay between dengue virus and the human innate immune system: a game of hide and seek. Vaccines (Basel) 7:145","journal-title":"Vaccines (Basel)"},{"key":"5298_CR121","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1538\/expanim.63.367","volume":"63","author":"K Tsukiyama-Kohara","year":"2014","unstructured":"Tsukiyama-Kohara K, Kohara M (2014) Tupaia belangeri as an experimental animal model for viral infection. Exp Anim 63:367\u2013374","journal-title":"Exp Anim"},{"key":"5298_CR122","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s13365-012-0117-y","volume":"18","author":"ML Velandia-Romero","year":"2012","unstructured":"Velandia-Romero ML, Acosta-Losada O, Castellanos JE (2012) In vivo infection by a neuroinvasive neurovirulent dengue virus. J Neurovirol 18:374\u2013387","journal-title":"J Neurovirol"},{"key":"5298_CR123","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0264-410X(98)00393-4","volume":"17","author":"J Velzing","year":"1999","unstructured":"Velzing J, Groen J, Drouet MT, van Amerongen G, Copra C, Osterhaus AD, Deubel V (1999) Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine 17:1312\u20131320","journal-title":"Vaccine"},{"key":"5298_CR124","doi-asserted-by":"publisher","first-page":"e2040","DOI":"10.21769\/BioProtoc.2040","volume":"6","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Chan KWK, Vasudevan SG (2016) Mouse model of dengue virus infection with serotypes 1 and 2 clinical isolates. Bio-Protoc 6:e2040","journal-title":"Bio-Protoc"},{"key":"5298_CR125","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4269\/ajtmh.1987.36.143","volume":"36","author":"DM Watts","year":"1987","unstructured":"Watts DM, Burke DS, Harrison BA, Whitmire RE, Nisalak A (1987) Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg 36:143\u2013152","journal-title":"Am J Trop Med Hyg"},{"key":"5298_CR126","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4269\/ajtmh.2001.65.379","volume":"65","author":"DT Williams","year":"2001","unstructured":"Williams DT, Daniels PW, Lunt RA, Wang LF, Newberry KM, Mackenzie JS (2001) Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses. Am J Trop Med Hyg 65:379\u2013387","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"5298_CR127","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1111\/j.1749-6632.2009.05057.x","volume":"1171","author":"KL Williams","year":"2009","unstructured":"Williams KL, Zompi S, Beatty PR, Harris E (2009) A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci 1171(Suppl 1):E12-23","journal-title":"Ann N Y Acad Sci"},{"key":"5298_CR128","unstructured":"World Health Organization (2020) Dengue and severe dengue. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue. Accessed 23 Mar 2021"},{"key":"5298_CR129","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.antiviral.2008.06.010","volume":"80","author":"LE Yauch","year":"2008","unstructured":"Yauch LE, Shresta S (2008) Mouse models of dengue virus infection and disease. Antiviral Res 80:87\u201393","journal-title":"Antiviral Res"},{"key":"5298_CR130","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","volume":"182","author":"LE Yauch","year":"2009","unstructured":"Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, Prestwood TR, Sette A, Shresta S (2009) A protective role for dengue virus-specific CD8+ T cells. J Immunol 182:4865\u20134873","journal-title":"J Immunol"},{"key":"5298_CR131","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00705-013-1618-6","volume":"158","author":"T Yoshida","year":"2013","unstructured":"Yoshida T, Omatsu T, Saito A, Katakai Y, Iwasaki Y, Kurosawa T, Hamano M, Higashino A, Nakamura S, Takasaki T, Yasutomi Y, Kurane I, Akari H (2013) Dynamics of cellular immune responses in the acute phase of dengue virus infection. Arch Virol 158:1209\u20131220","journal-title":"Arch Virol"},{"key":"5298_CR132","doi-asserted-by":"publisher","first-page":"e1002780","DOI":"10.1371\/journal.ppat.1002780","volume":"8","author":"CY Yu","year":"2012","unstructured":"Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL (2012) Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 8:e1002780","journal-title":"PLoS Pathog"},{"key":"5298_CR133","first-page":"194","volume":"15","author":"J Yuwono","year":"1984","unstructured":"Yuwono J, Suharyono W, Koiman I, Tsuchiya Y, Tagaya I (1984) Seroepidemiological survey on dengue and Japanese encephalitis virus infections in Asian monkeys. Southeast Asian J Trop Med Public Health 15:194\u2013200","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5298_CR134","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","volume":"7","author":"RM Zellweger","year":"2010","unstructured":"Zellweger RM, Prestwood TR, Shresta S (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7:128\u2013139","journal-title":"Cell Host Microbe"},{"key":"5298_CR135","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","volume":"193","author":"RM Zellweger","year":"2014","unstructured":"Zellweger RM, Eddy WE, Tang WW, Miller R, Shresta S (2014) CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol 193:4117\u20134124","journal-title":"J Immunol"},{"key":"5298_CR136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","volume":"5","author":"RM Zellweger","year":"2014","unstructured":"Zellweger RM, Shresta S (2014) Mouse models to study dengue virus immunology and pathogenesis. Front Immunol 5:151","journal-title":"Front Immunol"},{"key":"5298_CR137","doi-asserted-by":"publisher","first-page":"e01982-18","DOI":"10.1128\/JVI.01982-18","volume":"93","author":"NN Zhang","year":"2019","unstructured":"Zhang NN, Zhang L, Deng YQ, Feng Y, Ma F, Wang Q, Ye Q, Han Y, Sun X, Zhang FC, Qi X, Wang G, Dai J, Xia X, Qin CF (2019) Zika virus infection in Tupaia belangeri causes dermatological manifestations and confers protection against secondary infection. J Virol 93:e01982-18","journal-title":"J Virol"},{"key":"5298_CR138","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12250-020-00229-y","volume":"35","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Li M, Liu Z, Jin X, Sun J (2020) Establishment of murine infection models with biological clones of dengue viruses derived from a single clinical viral isolate. Virol Sin 35:626\u2013636","journal-title":"Virol Sin"},{"key":"5298_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/v4010062","volume":"4","author":"S Zompi","year":"2012","unstructured":"Zompi S, Harris E (2012) Animal models of dengue virus infection. Viruses 4:62\u201382","journal-title":"Viruses"},{"key":"5298_CR140","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1128\/JVI.03827-13","volume":"88","author":"R Zust","year":"2014","unstructured":"Zust R, Toh YX, Valdes I, Cerny D, Heinrich J, Hermida L, Marcos E, Guillen G, Kalinke U, Shi PY, Fink K (2014) Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines. J Virol 88:7276\u20137285","journal-title":"J Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-05298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-021-05298-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-05298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T03:20:40Z","timestamp":1675912840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-021-05298-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5298"],"URL":"https:\/\/doi.org\/10.1007\/s00705-021-05298-2","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"21 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}